Pictet Asset Management Holding Sa Celldex Therapeutics, Inc. Transaction History
Pictet Asset Management Holding Sa
- $93.5 Billion
- Q2 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 1,300,329 shares of CLDX stock, worth $30.9 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,300,329
Previous 957,794
35.76%
Holding current value
$30.9 Million
Previous $17.4 Million
52.22%
% of portfolio
0.03%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding CLDX
# of Institutions
197Shares Held
68.2MCall Options Held
208KPut Options Held
238K-
Kynam Capital Management, LP Princeton, NJ6.1MShares$145 Million14.83% of portfolio
-
Wellington Management Group LLP Boston, MA5.23MShares$125 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$112 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$94.2 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$90.9 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.11B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...